524238 GUJINJEC

Gujarat Inject (Kerala) Share Price

 

Stock touched ten year high

 

Start SIP in GUJINJEC

Start SIP

Performance

  • Low
  • ₹36
  • High
  • ₹37
  • 52 Week Low
  • ₹17
  • 52 Week High
  • ₹37
  • Open Price₹37
  • Previous Close₹36
  • Volume141,553

Investment Returns

  • Over 1 Month + 29.11%
  • Over 3 Month + 82.41%
  • Over 6 Month + 48.49%
  • Over 1 Year + 37.01%

Smart Investing Starts Here Start SIP with Gujarat Inject (Kerala) for Steady Growth!

Invest Now

Gujarat Inject (Kerala) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 125.6
  • PEG Ratio
  • -2.8
  • Market Cap Cr
  • 54
  • P/B Ratio
  • 5.3
  • Average True Range
  • 1.36
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 2.02
  • RSI
  • 83.39
  • MFI
  • 100

Gujarat Inject (Kerala) Financials

Gujarat Inject (Kerala) Technicals

EMA & SMA

Current Price
₹36.50
+ 0.53 (1.47%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹33.03
  • 50 Day
  • ₹29.46
  • 100 Day
  • ₹26.70
  • 200 Day
  • ₹24.36

Resistance and Support

36.45 Pivot Speed
  • R3 38.30
  • R2 37.64
  • R1 37.11
  • S1 35.92
  • S2 35.26
  • S3 34.73

Gujarat Inject (Kerala) Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-14 Quarterly Results
2025-05-20 Audited Results
2025-02-18 Stock Split
2025-01-23 Quarterly Results

Gujarat Inject (Kerala) F&O

Gujarat Inject (Kerala) Shareholding Pattern

0%
92.83%
7.17%

Gujarat Inject (Kerala) FAQs

Gujarat Inject (Kerala) share price is ₹36 As on 02 January, 2026 | 19:17

The Market Cap of Gujarat Inject (Kerala) is ₹53.5 Cr As on 02 January, 2026 | 19:17

The P/E ratio of Gujarat Inject (Kerala) is 125.6 As on 02 January, 2026 | 19:17

The PB ratio of Gujarat Inject (Kerala) is 5.3 As on 02 January, 2026 | 19:17

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23